Nové postupy v antikoagulační léčbě u seniorů s fibrilací síní

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English New approaches in anticoagulant therapy in elderly patients with atrial fibrillation
Authors

ŠPÁC Jiří KIANIČKA Bohuslav

Year of publication 2012
Type Article in Periodical
Magazine / Source Kardiologická revue
MU Faculty or unit

Faculty of Medicine

Citation
Field Cardiovascular diseases incl. cardiosurgery
Keywords anticoagulation treatment; atrial fibrillation; warfarin; gatrans; xabans
Description New approaches to anticoagulant treatment for senior citizens with atrial fibrillation. Anticoagulant treatment for senior citizens with atrial fibrillation represents one of the most frequently administered treatments, with a relatively safe risk profile. Before beginning the procedure, it is necessary to carry out a risk assessment to assist the selection of a suitable therapy and in assessment of the risk of side-effects (bleeding). Until recently, the only anticoagulant was warfarin, which has a number of shortcomings. In recent years, a number of anticoagulant substances have appeared that block the functioning of thrombin or factor X, and which have shown in a number of clinical tests greater effectiveness in the prevenbon of thromboses connected to lower prevalence of bleeding. New anticoagulants have not only a number of advantages, but also some limitations that must be respected during treatment so that the benefits of new substances are not negated through incorrect use in practice.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.